3 Stocks Benefiting From Jaw-Dropping Growth in Specialty Drug Spending
Spending on specialty drugs soared 31% last year, boosting sales at Gilead Sciences, Celgene Corporation, and AbbVie Inc.
3 Biotech Stocks Wall Street Loves
Wall Street analysts love these biotech stocks. Should you?
Should Gilead Sciences Inc.’s Slowing Growth Concern Investors?
Gilead Sciences has been one of the fastest-growing biotech companies over the past few years. The company's rocket-like growth trajectory, though, is expected to start slowing starting this year. Should investors be concerned?